Tenax, SEC, Scottish Parliament: Could conference call bring clarity?
In my posting #7583 I pointed out that the Scottish Parliament took full acknowledgment of the ongoing development of Oxycyte for a new stroke therapy. The Scottish Parliament’s Motion S4M-14835 by Bob Doris, one of the leading Scottish health politicians, states: “[The Scottish Parliament] encourages the continued relationship between Aurum Biosciences and Tenax Therapeutics to provide for Aurum Biosciences to further develop Oxycyte.” Aurum Biosciences announced, that it is going to lead Oxycyte (drug owned by Tenax) into a phase 2a trial in Q1 2018. That proves, that this joint Tenax-Aurum development project has been ongoing for years and is now entering a crucial phase.
In strange contrast to what the Scottish State says, Tenax’s CEO Michael B. Jebsen has been telling the SEC for years, that no development involving Oxycyte is taking place. In his SEC FORM 10-K Commission File No. 001-34600 one can read the following statement: “We have previously developed Oxycyte, a PFC-based oxygen carrier (…). As we have suspended the development of these PFC products (…), we do not expect that Oxycyte, Dermacyte or Wundecyte constitute a material portion of our business going forward.”
Can SEC conference call bring clarity?
Thus, the Scottish Parliament tells us a completely different story than does Michael B. Jebsen, CEO of Tenax. The case seems to be clear to all Tenax shareholders: Probably all the Motions in the Scottish Parliament are lies, whereas the honorable Mr. Jebsen is always telling the truth. Could it therefore be that a conference call between Mr. Jebsen, the SEC and Bob Doris, member of the Scottish Parliament and leading Scottish health politician, could bring light into this mystery? Such a SEC conference call would provide Mr. Jebsen with the unique opportunity to tell Mr. Bob Doris, that he considers him a Scottish clown, and to tell the SEC, that no joint Tenax-Aurum research project is taking place, and that no phase 2a trial with Oxycyte is about to start in Q1 2018 – exactly as stated in the SEC filings. And Mr. Bob Doris, member of the Scottish Parliament, could use the conference call to tell the SEC that his Motion S4M-14835 is indeed a mere piece of clownery and that indeed the whole Scottish Parliament is a circus full of clowns. No doubt, such a happy talk would bring a great deal of clarity!
The question however, weather Michael B. Jebsen is really the adequate person to represent Tenax in this conference call (and in all future calls and business dealings), should best be decided this weekend – because later some kind of official machinery might be triggered, and such a machinery could prove difficult to be controlled.
Shall dear and very cozy Rumpelstilz help in paving the way for the SEC conference call? For example, by sending preparatory emails to people like Bob Doris or the Board of Governors of the Scottish Welcome Trust or his good old friends from the ICE and the QEUH, and by asking them why their Motions in the Scottish Parliament and their statements on their homepages tell exactly the opposite of what our honest Mr. Jebsen is telling in his certainly truthful SEC filings and on his certainly truthful homepage, where he last week - very truthfully, of course - deleted all the information relating to the Tenax-Aurum project (for details go to posting #7578 on this discussion board)? And by telling them that therefore compliance of the Tenax-Aurum treaty and thus the whole development project of the ICE is in danger? Rumpelstilz has always been nice and willing to stretch out a helping hand to anybody who is in need of help. And Mr. Jebsen seems to be very much in need of a strong, strong hand that helps him dial the right phone number for the SEC conference call. For full facts, go to posting #7583 on this discussion board.
